Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/16/2025

HSV-1 and HSV-2 Infection Characteristics

Anatomical Preferences and Epidemiology

  • HSV-1 traditionally manifests above the neck, while HSV-2 typically affects areas below the waist, though this distinction is not absolute due to oro-genital sexual practices 1, 2
  • HSV-1 has a higher prevalence, approximately 47.8% of the US population aged 14-49, compared to HSV-2, which has a prevalence of 12.1% in the same population 2

Clinical Manifestations

  • Orolabial herpes, typically caused by HSV-1, presents with a sensory prodrome followed by lesion evolution from papule to vesicle, ulcer, and crust stages on the lips, and can be triggered by sunlight or physiologic stress 3
  • Genital herpes, typically caused by HSV-2, often presents with similar lesion appearance and evolution to orolabial herpes, and is often accompanied by local symptoms including pain, pruritis, dysuria, vaginal/urethral discharge, and inguinal lymphadenopathy 3
  • Most cases of genital herpes progress subclinically but may become symptomatic at any time, with 80-90% of cases being asymptomatic 4, 5

Recurrence Patterns

  • HSV-2 recurs much more frequently in the genital area than HSV-1, with a higher monthly recurrence frequency 1, 3

Transmission and Infection

  • The incubation period for both HSV-1 and HSV-2 is typically 2-10 days, up to 4 weeks 4, 5

Primary vs. Recurrent Infection

  • Primary infection is typically the most severe manifestation, and both viruses establish latency in sensory ganglia, with HSV-1 in the trigeminal ganglia and HSV-2 in the sacral ganglia 4, 5

Diagnostic Considerations

  • Laboratory confirmation is essential, and recommended diagnostic methods include viral culture, HSV DNA PCR, HSV antigen detection, and type-specific serologic assays, as type determination helps predict recurrence patterns and guide counseling 3

Clinical Implications

  • HSV-2 is a risk factor for HIV acquisition, and HSV-2 reactivation can increase HIV RNA levels in coinfected patients, with neonatal herpes and increased risk for acquiring HIV being the most serious complications of genital herpes infections 3, 4, 5
  • Both infections are lifelong, with the virus remaining in a non-multiplying episomal form in neural ganglia during latency periods 4, 5

Clinical Manifestations of HSV-1 and HSV-2

Primary Infection

  • Primary HSV-1 gingivostomatitis presents with fever, irritability, tender submandibular lymphadenopathy, and painful oral/perioral ulcers, according to the MMWR Recommendations and Reports 6

Key Differences Between HSV-1 and HSV-2 Infections

Anatomical Distribution and Transmission

  • HSV-1 traditionally manifests above the neck, typically acquired through non-sexual contact, often during childhood via saliva or direct contact with infected lesions, according to the European surveillance data 7
  • HSV-2 infection carries more stigma because it is almost exclusively associated with genital disease, whereas HSV-1 is associated with both oropharyngeal and genital disease 7

Recurrence Patterns and Clinical Behavior

  • Genital HSV-1 infections have a more benign natural history with fewer recurrences compared to genital HSV-2, which is critical for patient counseling, as stated by the Clinical Infectious Diseases guidelines 8
  • Type-specific testing is essential because it predicts recurrence patterns and guides patient counseling about expected natural history, as recommended by the Clinical Infectious Diseases guidelines 8